InsidersTradesSigma
Total declarations
Company
▲ Purchases (37 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by FROST PHILLIP MD ET AL. Insider active across 1 companies, notably Opko Health, INC.. Cumulatively, 37 disclosures have been recorded. Total volume traded: €4.7m. The latest transaction was filed on 21 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations37 total
€67,28629,715 shares@ €2.26440.0070% mcap1.4% of flow
Common Stock
SEC:0001209191-22-038619:0·
Ideal exit: 18 Mar 2023 (T+270)
€20,7129,560 shares@ €2.16650.0022% mcap0.4% of flow
Common Stock
SEC:0001209191-22-037687:0·
Ideal exit: 13 Mar 2023 (T+270)
€1,588700 shares@ €2.26830.0002% mcap0.0% of flow
Common Stock
SEC:0001209191-22-036571:0·
Ideal exit: 10 Mar 2023 (T+270)
€129,54350,000 shares@ €2.59090.014% mcap2.8% of flow
Common Stock
SEC:0001209191-22-034751:0·
Ideal exit: 3 Mar 2023 (T+270)
€13,7505,000 shares@ €2.75010.0014% mcap0.3% of flow
Common Stock
SEC:0001209191-22-033343:0·
Ideal exit: 26 Feb 2023 (T+270)
€1,397500 shares@ €2.79480.0001% mcap0.0% of flow
Common Stock
SEC:0001209191-22-033052:0·
Ideal exit: 25 Feb 2023 (T+270)
€35,53812,852 shares@ €2.76510.0037% mcap0.8% of flow
Common Stock
SEC:0001209191-22-032025:0·
Ideal exit: 19 Feb 2023 (T+270)
€18,5876,806 shares@ €2.73090.0019% mcap0.4% of flow
Common Stock
SEC:0001209191-22-030309:0·
Ideal exit: 12 Feb 2023 (T+270)
€1,868660 shares@ €2.83070.0002% mcap0.0% of flow
Common Stock
SEC:0001209191-22-029463:0·
Ideal exit: 10 Feb 2023 (T+270)
€3,1261,100 shares@ €2.84210.0003% mcap0.1% of flow
Common Stock
SEC:0001209191-22-029018:0·
Ideal exit: 7 Feb 2023 (T+270)
€1m400,000 shares@ €2.6930.11% mcap22.9% of flow
Common Stock
SEC:0001209191-22-028441:0·
Ideal exit: 5 Feb 2023 (T+270)
€1m400,000 shares@ €2.6430.11% mcap22.5% of flow
Common Stock
SEC:0001209191-22-028189:0·
Ideal exit: 4 Feb 2023 (T+270)
€27,5469,955 shares@ €2.76710.0029% mcap0.6% of flow
Common Stock
SEC:0001209191-22-018683:0·
Ideal exit: 9 Dec 2022 (T+270)
€283100 shares@ €2.83280.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-22-018347:0·
Ideal exit: 6 Dec 2022 (T+270)
€12,9684,700 shares@ €2.75910.0014% mcap0.3% of flow
Common Stock
SEC:0001209191-22-013836:0·
Ideal exit: 25 Nov 2022 (T+270)
€2m750,000 shares@ €2.75860.22% mcap44.0% of flow
Common Stock
SEC:0001209191-22-013440:0·
Ideal exit: 22 Nov 2022 (T+270)
€35,21213,273 shares@ €2.65290.0037% mcap0.7% of flow
Common Stock
SEC:0001209191-22-009634:0·
Ideal exit: 11 Nov 2022 (T+270)
€3,2001,200 shares@ €2.6670.0003% mcap5.1% of flow
Common Stock
SEC:0001209191-22-006172·
Ideal exit: 29 Oct 2022 (T+270)
€3,2001,200 shares@ €2.6670.0003% mcap0.1% of flow
Common Stock
SEC:0001209191-22-006172:0·
Ideal exit: 29 Oct 2022 (T+270)
€2,321900 shares@ €2.57860.0002% mcap0.0% of flow
Common Stock
SEC:0001209191-22-005138:0·
Ideal exit: 23 Oct 2022 (T+270)
€2,321900 shares@ €2.57860.0002% mcap3.7% of flow
Common Stock
SEC:0001209191-22-005138·
Ideal exit: 23 Oct 2022 (T+270)
€1,459500 shares@ €2.91830.0002% mcap2.3% of flow
Common Stock
SEC:0001209191-21-056095·
Ideal exit: 11 Jun 2022 (T+270)
€1,459500 shares@ €2.91830.0002% mcap0.0% of flow
Common Stock
SEC:0001209191-21-056095:0·
Ideal exit: 11 Jun 2022 (T+270)
€14,1474,518 shares@ €3.13130.0015% mcap22.3% of flow
Common Stock
SEC:0001209191-21-051524·
Ideal exit: 10 May 2022 (T+270)
€14,1474,518 shares@ €3.13130.0015% mcap0.3% of flow
Common Stock
SEC:0001209191-21-051524:0·
Ideal exit: 10 May 2022 (T+270)
25 of 37 declarations
About FROST PHILLIP MD ET AL
Frost Phillip MD et al is a significant shareholder of OPKO Health, Inc.
